Clinical Trial Update: SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SJ901 evaluating mirdametinib in children, adolescents, and young adults with low-grade glioma; the Phase 1/Phase 2 study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma

Drugs mentioned

• Mirdametinib (mirdametinib)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Low-Grade Glioma, Recurrent Low-Grade Glioma | Phase 1, Phase 2 | Status: RECRUITING